Company Nutriband Inc. Other OTC
Equities
NTRB
US67092M2089
Medical Equipment, Supplies & Distribution
Business Summary
Sales per Business
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Pocono Pharmaceuticals
92.1
%
| 2 | 85.9 % | 2 | 92.1 % | +7.54% |
4P Therapeutics
7.9
%
| 0 | 14.1 % | 0 | 7.9 % | -43.89% |
Sales per region
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | +0.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gareth Sheridan
FOU | Founder | 35 | 31/12/11 |
Serguei Melnik
FOU | Founder | 52 | 31/12/11 |
Gerald Goodman
DFI | Director of Finance/CFO | 76 | 30/07/18 |
Patrick Ryan
CTO | Chief Tech/Sci/R&D Officer | 38 | 31/01/18 |
Jeffrey Patrick
CTO | Chief Tech/Sci/R&D Officer | 55 | 14/05/18 |
Alan Smith
COO | Chief Operating Officer | 59 | 31/07/18 |
Larry Dillaha
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/08/18 |
- | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Serguei Melnik
FOU | Founder | 52 | 31/12/11 |
Stefan Mancas
BRD | Director/Board Member | 48 | 30/06/18 |
Gareth Sheridan
FOU | Founder | 35 | 31/12/11 |
Mark Hamilton
BRD | Director/Board Member | 39 | 30/06/18 |
Radu Bujoreanu
BRD | Director/Board Member | 53 | 13/06/19 |
Director/Board Member | 36 | 20/01/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,046,100 | 6,110,597 ( 55.32 %) | 10,000 ( 0.0905 %) | 55.32 % |
Company contact information
Nutriband, Inc.
121 South Orange Avenue Suite 1500
32801, Orlando
+407 377 6695
http://www.nutriband.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-2.34% | 187B | |
+0.92% | 110B | |
-1.77% | 69.54B | |
+14.21% | 46.37B | |
-6.06% | 46.05B | |
+7.97% | 42.54B | |
+19.03% | 30.72B | |
+17.70% | 25.62B | |
-7.25% | 23.32B |